Dogwood Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
DWTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
44 Milton Avenue, Alpharetta, GA

There are no Buy or Sell transactions made by insiders since 11/26/2024

Dogwood Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sealbond Ltd Director, Other*, 10%+ Owner $164M Nov 21, 2025
William Pridgen Director $992K Feb 26, 2024
CK Life Sciences Intl (Holdings) Inc Director, Other*, 10%+ Owner $1.99K Mar 12, 2025
Ralph Grosswald Svp Of Operations Jun 27, 2025
David R. Keefer Director Jun 27, 2025
Abel De La Rosa Director Jun 27, 2025
Gregory Scott Duncan CHIEF EXECUTIVE OFFICER, Director Jun 27, 2025
Conjoint Inc. Director, Other*, 10%+ Owner Mar 12, 2025
Roger Michael Gendreau Chief Medical Officer Jun 27, 2025
Angela Walsh Chief Financial Officer Jun 27, 2025
John C. Thomas Director Jun 27, 2025
Richard James Whitley Director Jun 27, 2025
Richard Alan Burch Director Feb 26, 2024
Yu Ying Choi Alan Abel Director Oct 7, 2024
Toh Kean Meng Melvin Director Oct 7, 2024

Recent Insider Transactions by Companies or Individuals for Dogwood Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.